Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients
Clinical trial NCT03781479 · COMPLETED
Trial details
- NCT number
- NCT03781479
- Sponsor
- Catalyst Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-21
- Primary completion
- 2020-07-23
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.